WorldHeart Will End Its Levacor VAD Program; Will Focus on Developing Its Next-Generation MiFlow Miniature Ventricular Assist Device

World Heart Corporatio

announced today that it will cease its efforts to commercialize the Levacor ventricular assist device technology and will focus its resources on developing and commercializing its smaller, next-generation MiFlow VAD.